Back
Catalyst Pharmaceuticals, Inc. Vs. ADMA Biologics, Inc. Industry Stock Comparison
Buy
81
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$24.11
Seasonality Move:
14.38%
Buy
72
ADMA
ADMA Biologics, Inc.
Last Price:
$19.06
Seasonality Move:
14.27%
Buy
81
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.35. The Score for CPRX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
72
ADMA Biologics, Inc. (ADMA)
is a Buy
Is ADMA Biologics, Inc. a Buy, Sell or Hold?
-
The current ADMA Biologics, Inc. [ADMA] share price is $19.28. The Score for ADMA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals, Inc.'s stock price today?
-
The Catalyst Pharmaceuticals, Inc. share price today is $24.35The current trend is moderately bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADMA Stock Price Chart
What is ADMA Biologics, Inc.'s stock price today?
-
The ADMA Biologics, Inc. share price today is $19.28The current trend is moderately bearish and ADMA is experiencing selling pressure, which indicates risk of future bearish movement.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 62.99 | Buy |
| Chaikin Money Flow: | 361542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.91 - 24.07) | Buy |
| Bollinger Bands (100): | (19.92 - 22.86) | Buy |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 55.49 | Buy |
| Chaikin Money Flow: | -745147 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.39 - 20.11) | Buy |
| Bollinger Bands (100): | (14.89 - 18.47) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.12 | Buy |
| 20-day SMA: | 23.53 | Buy |
| 50-day SMA: | 22.55 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 24.1 | Buy |
| 20-day EMA: | 23.64 | Buy |
| 50-day EMA: | 22.45 | Buy |
| 200-day EMA: | 14.22 | Buy |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.32 | Sell |
| 20-day SMA: | 19.56 | Sell |
| 50-day SMA: | 17.24 | Buy |
| 200-day SMA: | 18.19 | Buy |
| 8-day EMA: | 19.44 | Sell |
| 20-day EMA: | 19.1 | Buy |
| 50-day EMA: | 17.96 | Buy |
| 200-day EMA: | 17.32 | Buy |
Catalyst Pharmaceuticals, Inc. Earnings Growth & CPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.
ADMA Biologics, Inc. Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.34 per share.
Catalyst Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||